Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies.

H Prins, Martin; Wa Lensing, Anthonie; Bauersachs, Rupert; van Bellen, Bonno; Bounameaux, Henri; A Brighton, Timothy; T Cohen, Alexander; L Davidson, Bruce; Decousus, Hervé; E Raskob, Gary; D Berkowitz, Scott; S Wells, Philip; Investigators, EINSTEIN

doi:10.1186/1477-9560-11-21

Public

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies.

Shared by NobleBlocks on Sep 20, 2013 • 12:00 AM UTC

Authors:

Martin H Prins

Anthonie Wa Lensing

Rupert Bauersachs

Abstract

BACKGROUND: Standard treatment for venous thromboembolism (VTE) consists of a heparin combined with vitamin K antagonists. Direct oral anticoagulants have been investigated for acute and extended treatment of symptomatic VTE; their use could avoid parenteral treatment and/or laboratory monitoring of...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!